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to cross-recognize the self-HSP homologs of stressed cells. Since 
then, the research in the immunology of stress proteins started to 
comprise a widening spectrum of topics with potential medical 
relevance. Interestingly, since stress proteins have their activities in 
both innate and adaptive immunity, they are key elements in the 
cross-roads between both arms of the immune system.
Stress proteins or HSP can be considered as functional “bio-
markers” of inflammation. They are up-regulated locally during 
inflammation and interestingly, they seem to function as targets for 
anti-inflammatory regulatory T cells (Figure 1). In experimental 
Stress proteins or heat shock proteins (HSP) are evolutionary 
conserved proteins present in every prokaryotic and eukaryotic 
cell. Their archetypical function is to protect cells and proteins 
from damage under stressful circumstances. The latter circum-
stances do include the cell and protein damaging effects of 
inflammation.
The discovery of mycobacterial HSP60 being a critical antigen 
in the model of adjuvant arthritis, has led to studies that showed 
the immuno-dominance of microbial HSP60 and the potential of 
the microbial HSP induced repertoire of antibodies and T cells 
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Figure 1 | HSP-specific immunoregulation in the healthy and aged 
immune system. Self-HSP-specific T cells reside in the circulation after 
escape from central tolerance in the thymus. Since HSP are highly conserved, 
these self-HSP-specific T cells can cross-recognize bacterial HSP. This T cell 
population can be expanded after exposure to bacterial-HSP at mucosal 
surfaces like the gut or during infection. At mucosal surfaces, these T cells will 
be directed toward a regulatory phenotype through mechanisms of mucosal 
tolerance. In addition, Treg induction and maintenance will be promoted by 
stress induced HSP expression in peripheral tissues, because up-regulation of 
self-HSP and presentation of HSP peptides by MHC class II can occur in the 
absence of co-stimulation. Treg induction will be enhanced by IL-10 produced in 
response to stress. Furthermore, self-HSP peptides can function as altered 
peptide ligands for bacterial HSP-specific T cells. During inflammation, HSP will 
be induced and presented on professional APCs at the inflammatory site, 
leading to full activation of HSP-specific Treg and local dampening ongoing 
inflammation. In the aged immune system stress induced HSP expression is 
decreased. Therefore, reduced HSP inducibility will probably influence both the 
induction of HSP-specific Treg in the periphery and their activation during 
inflammation. Ultimately this could result in reduced Treg numbers and 
function.
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models of autoimmunity, mainly arthritis, administration of HSP 
peptides has been shown to suppress disease. First clinical trials 
have shown the anti-inflammatory nature of T cell responses to 
HSP. In type I diabetes and in rheumatoid arthritis, parenteral and 
oral administration of HSP peptides were shown to induce a bias 
in pro-inflammatory T cells, switching them in the direction of 
regulatory cytokine production (IL4, IL5, and IL-10). In addition a 
raised level of a marker of T regulatory cells, the transcription factor 
FoxP3, was noted in the RA trial. Other inflammatory diseases or 
diseases with inflammatory components which feature the immune 
imprint of the up-regulated HSP are atherosclerosis, inflammatory 
bowel diseases, multiple sclerosis, and atopic diseases such as atopic 
dermatitis and allergic asthma. The review by Borges et al. (2012) 
discusses the effects of HSP70 on the induction of tolerance at the 
level of antigen presenting cells and T cells. By this, HSP70 could 
lead to the development of innovative anti-inflammatory agents 
to use against autoimmunity and transplant rejection. Shields et al. 
(2012) have contributed with a review where inhibition and termi-
nation of immune responses using BiP (HSP70) are highlighted. 
They have introduced the term resolution promoting proteins for 
the aspects of HSPs (Resolution Associated Molecular Patterns or 
RAMPs). The function of small heat shock proteins (sHSP) in neu-
rological diseases is discussed in the review by Brownell et al. (2012). 
It highlights the potential of using HSP as novel neuroprotective 
therapeutics. The ins and outs of HSP as immunoregulatory agents 
are discussed in more general terms in the review by Coelho and 
Faria (2012). Aalberse et al. (2012) have broadened the potential 
of anti-inflammatory effects of HSP in the area of atopic diseases. 
With the example of HSP60 it is argued that anti-microbial HSP 
immune reactivity may contribute to atopic disease resistance, sug-
gesting that HSP immunity can constitute the molecular basis of 
the hygiene hypothesis.
Tumor associated stress proteins seem to qualify as prognostic 
biomarkers in many tumors. This may be caused by their activity 
as cellular stress-resistance enhancers. In addition, it may relate 
to the cell biology of metastasis or to their functions as targets of 
regulatory T cells. Despite the lack of membrane anchor sequences 
in HSP, there is ample evidence for cell surface expressed members 
of stress proteins. In the case of tumors they may then function as 
targets for NK cells. The review articles of Multhoff et al. (2012) and 
Calderwood et al. (2012) articulate two additional aspects of stress 
proteins in cancer development. Whereas both papers discuss the 
role of HSP as danger molecules, promoting anti-tumor inflam-
mation, Multhoff et al. (2012) also discuss the tumor promoting 
anti-apoptotic effects of HSP. Calderwood et al. (2012) discuss the 
anti-tumor immune stimulatory effects of HSP on helper cells and 
antigen presenting cells. The issue of cell surface expression of HSP 
seems also relevant for endoplasmic reticulum (ER) stress proteins. 
As argued in the review by Morito and Nagata (2012), these proteins 
can also be cell surface expressed and have pathophysiological roles 
in autoimmunity and inflammation.
A controversy in the area has arisen concerning claims of stress 
proteins as danger molecules that have the innate quality of inducing 
inflammatory responses in dendritic cells or other antigen present-
ing cells. Apart from the possible contribution of contaminating 
LPS present in earlier recombinant HSP preparations, there is good 
evidence that cells may perceive stress proteins as danger molecules, 
indeed. The mechanisms involved in these stress protein activities 
are ready to be sorted out, amongst others motivated by findings that 
show additional potential of stress proteins as carriers for protein 
or oligosaccharide epitopes or as immune stimulatory adjuvants in 
vaccines. This issue of HSP seen as damage associated molecular 
patterns (DAMPs) is dealt with in the perspective by Land (2012). 
The argument in favor of HSP functioning as DAMPs is presented 
regardless of the final positive or negative regulatory function of 
HSP. Another aspect of the dual functional role of HSP in immune 
regulation is highlighted in the mini review by Lee and Repasky 
(2012). Based on findings that mild hyperthermia can lead to both 
pro- and anti-inflammatory effects in macrophages, it is proposed 
that activation state of macrophages is the determining factor in this.
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